secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001628908-23-000192
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health issues $402.5M convertible notes at 3.50%, repays $405M term loan
--------------------------------------------------------------------------------

- Issued $402.5M aggregate principal of 3.50% convertible senior notes due 2029; net proceeds ~$390.2M.
- Initial conversion price ~$38.00/share, a 42.5% premium over Dec 5 closing price of Class A common stock.
- Proceeds used to prepay $405.0M term loan principal plus $9.1M accrued interest and $10.1M prepayment premium.
- Notes convertible into up to 10.59M shares of Class A common stock; Company may elect cash or shares upon conversion.
- Credit agreement amended to permit note issuance; $37.5M remains outstanding on revolving credit facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000192/0001628908-23-000192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000192/evh-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer